Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers

Gangadharan B.; Kumar A.; Cobbold J.; Dwek RA.; Thursz M.; Zitzmann N.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers

Gangadharan B., Kumar A., Cobbold J., Dwek RA., Thursz M., Zitzmann N.

The invention relates to methods of diagnosing, prognosing, or monitoring or staging the progression of non-alcoholic fatty liver disease (NAFLD) using biomarkers. The invention also relates to a method of scoring to determine the severity of NAFLD, and a method of treating NAFLD.

Type

Patent

Publication Date

01/03/2018